Related references
Note: Only part of the references are listed.Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA
B. J. Metcalf et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective
Lindsay Kim et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014
Satoshi Nakano et al.
VACCINE (2016)
Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacement
William P. Hausdorff et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany
Matthias Imoehl et al.
BMC INFECTIOUS DISEASES (2015)
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis in US Children
Liset Olarte et al.
CLINICAL INFECTIOUS DISEASES (2015)
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance
Matthew R. Moore et al.
LANCET INFECTIOUS DISEASES (2015)
Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia
Ankita P. Desai et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2015)
Impact of the 13-valent pneumococcal conjugate vaccine (pcv13) on invasive pneumococcal disease and carriage in Alaska
Michael G. Bruce et al.
VACCINE (2015)
Nationwide population-based surveillance of invasive pneumococcal disease in Japanese children: Effects of the seven-valent pneumococcal conjugate vaccine
Shigeru Suga et al.
VACCINE (2015)
Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children
Emmanuelle Varon et al.
VACCINE (2015)
Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012
A. Lepoutre et al.
VACCINE (2015)
Estimation of the invasive disease potential of Streptococcus pneumoniae in children by the use of direct capsular typing in clinical specimens
E. del Amo et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany
Mark van der Linden et al.
PLOS ONE (2015)
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
Mirjam J. Knol et al.
EMERGING INFECTIOUS DISEASES (2015)
Early Impact of 13-Valent Pneumococcal Conjugate Vaccine on Community-Acquired Pneumonia in Children
F. Angoulvant et al.
CLINICAL INFECTIOUS DISEASES (2014)
Reduction of Invasive Pneumococcal Disease 3 Years After the Introduction of the 13-Valent Conjugate Vaccine in the Oxfordshire Region of England
Catrin E. Moore et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Effects of Vaccination on Invasive Pneumococcal Disease in South Africa
Anne von Gottberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Trends of Pneumococcal Meningitis in Children After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in France
Corinne Levy et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage
Katherine E. Fleming-Dutra et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)
Distribution of Serotypes, Vaccine Coverage, and Antimicrobial Susceptibility Pattern of Streptococcus Pneumoniae in Children Living in SAARC Countries: A Systematic Review
Nishant Jaiswal et al.
PLOS ONE (2014)
The incidence of pediatric invasive Haemophilus influenzae and pneumococcal disease in Chiba prefecture, Japan before and after the introduction of conjugate vaccines
Naruhiko Ishiwada et al.
VACCINE (2014)
Pneumococcal carriage in children and adults two years after introduction of the thirteen valent pneumococcal conjugate vaccine in England
Albert Jan van Hoek et al.
VACCINE (2014)
European enhanced surveillance of invasive pneumococcal disease in 2010: Data from 26 European countries in the post-heptavalent conjugate vaccine era
Adoracion Navarro Torne et al.
VACCINE (2014)
Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013
Marcela Guevara et al.
VACCINE (2014)
Impact of 13-Valent Pneumococcal Conjugate Vaccination on Streptococcus pneumoniae Carriage in Young Children in Massachusetts
Grace M. Lee et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2014)
Changes in Capsule and Drug Resistance of Pneumococci after Introduction of PCV7, Japan, 2010-2013
Naoko Chiba et al.
EMERGING INFECTIOUS DISEASES (2014)
Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012
Walter H. B. Demczuk et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2013)
Incidence of pneumococcal infections among children under 15 years in southern Catalonia throughout the heptavalent conjugate vaccine era, 2002-2009
A. Vila-Corcoles et al.
INFECTION (2013)
EMERGENCY DEPARTMENT EPIDEMIOLOGY OF PNEUMOCOCCAL BACTEREMIA IN CHILDREN SINCE THE INSTITUTION OF WIDESPREAD PCV7 VACCINATION
Rakesh D. Mistry et al.
JOURNAL OF EMERGENCY MEDICINE (2013)
Pneumococcal Carriage and Invasive Disease in Children Before Introduction of the 13-valent Conjugate Vaccine: Comparison With the Era Before 7-valent Conjugate Vaccine
Dolly Sharma et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Early Trends for Invasive Pneumococcal Infections in Children After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine
Sheldon L. Kaplan et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Pneumococcal Carriage in Young Children One Year after Introduction of the 13-Valent Conjugate Vaccine in Italy
Romina Camilli et al.
PLOS ONE (2013)
Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogota, Colombia
Eliana L. Parra et al.
VACCINE (2013)
Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway
Anneke Steens et al.
VACCINE (2013)
Serotype-Specific Changes in Invasive Pneumococcal Disease after Pneumococcal Conjugate Vaccine Introduction: A Pooled Analysis of Multiple Surveillance Sites
Daniel R. Feikin et al.
PLOS MEDICINE (2013)
PspA Family Distribution, unlike Capsular Serotype, Remains Unaltered following Introduction of the Heptavalent Pneumococcal Conjugate Vaccine
Christina M. Croney et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Invasive bacterial infections in a paediatric emergency department in the era of the heptavalent pneumococcal conjugate vaccine
Maria Herrero et al.
EUROPEAN JOURNAL OF EMERGENCY MEDICINE (2012)
Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada
Philippe De Wals et al.
VACCINE (2012)
Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA)
Atef M. Shibl et al.
VACCINE (2012)
Relationship between Serotypes, Age, and Clinical Presentation of Invasive Pneumococcal Disease in Madrid, Spain, after Introduction of the 7-Valent Pneumococcal Conjugate Vaccine into the Vaccination Calendar
J. Picazo et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Serotypes of Streptococcus pneumoniae Isolates from Children with Invasive Pneumococcal Disease in Turkey: Baseline Evaluation of the Introduction of the Pneumococcal Conjugate Vaccine Nationwide
Mehmet Ceyhan et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain
Carmen Munoz-Almagro et al.
JOURNAL OF INFECTION (2011)
Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, England
Dona Foster et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2011)
Serotype replacement in disease after pneumococcal vaccination
Daniel M. Weinberger et al.
LANCET (2011)
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study
Elizabeth Miller et al.
LANCET INFECTIOUS DISEASES (2011)
PNEUMOCOCCAL MENINGITIS IN FRENCH CHILDREN BEFORE AND AFTER THE INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE
Corinne Levy et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2011)
Invasive pneumococcal disease: Association between serotype, clinical presentation and lethality
Ma Angeles Gutierrez Rodriguez et al.
VACCINE (2011)
Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement
C. Alexandre et al.
ACTA PAEDIATRICA (2010)
Epidemiology of pediatric community-acquired bloodstream infections in a children hospital in Paris, France, 2001 to 2008
Catherine Doit et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Tamara Pilishvili et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Serotype 19A Is the Most Common Serotype Causing Invasive Pneumococcal Infections in Children
Sheldon L. Kaplan et al.
PEDIATRICS (2010)
The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007
Julie A. Bettinger et al.
VACCINE (2010)
Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease
Inci Yildirim et al.
VACCINE (2010)
Systematic Evaluation of Serotypes Causing Invasive Pneumococcal Disease among Children Under Five: The Pneumococcal Global Serotype Project
Hope L. Johnson et al.
PLOS MEDICINE (2010)
Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998-2007: Update from the Calgary-Area Streptococcus pneumoniae Research (CASPER) Study
James D. Kellner et al.
CLINICAL INFECTIOUS DISEASES (2009)
Changes in serotypes causing invasive pneumococcal disease (2005-2007 vs. 1997-1999) in children under 2 years of age in a population with intermediate coverage of the 7-valent pneumococcal conjugated vaccine
L. Salleras et al.
CLINICAL MICROBIOLOGY AND INFECTION (2009)
Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine
E. Perez-Trallero et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates
Katherine L. O'Brien et al.
LANCET (2009)
National paediatric immunization program of high risk groups: No effect on the incidence of invasive pneumococcal diseases
P. Rendi-Wagner et al.
VACCINE (2009)
Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine
S. I. Aguiar et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the united states during the era of widespread PCV7 vaccination, 1998-2004
Lauri A. Hicks et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumnococcal conjugate vaccine
Steven Black et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2007)
Effectiveness of the 7-valent pneumococcal conjugate vaccine: A population-based case-control study
Aurelio Barricarte et al.
CLINICAL INFECTIOUS DISEASES (2007)
Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine
J. Aristegui et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Invasive pneumococcal disease among children in a health district of Barcelona:: early impact of pneumococcal conjugate vaccine
E. Calbo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Changing epidemiology of outpatient bacteremia in 3-to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine
AM Herz et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the Intermountain West:: Emergence of nonvaccine serogroups
CL Byington et al.
CLINICAL INFECTIOUS DISEASES (2005)
Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine
K Hsu et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Share Paper
